Equities

Personalis Inc

Personalis Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)5.74
  • Today's Change-0.19 / -3.20%
  • Shares traded1.22m
  • 1 Year change+334.85%
  • Beta1.9230
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(108)(113)(65)
Depreciation/depletion118.436.01
Non-Cash items272420
Cash taxes paid, supplemental0.060.050.04
Cash interest paid, supplemental000
Changes in working capital1311(31)
Total cash from operations(56)(70)(71)
INVESTING
Capital expenditures(11)(50)(11)
Other investing and cash flow items, total24102(49)
Total cash from investing1353(60)
FINANCING
Financing cash flow items00(0.34)
Total cash dividends paid------
Issuance (retirement) of stock, net4.862.47167
Issuance (retirement) of debt, net6.17(1.1)3.31
Total cash from financing111.37170
NET CHANGE IN CASH
Foreign exchange effects(0.02)(0.13)0.05
Net change in cash(32)(16)39
Net cash-begin balance/reserved for future use9110769
Net cash-end balance/reserved for future use5991107
SUPPLEMENTAL INCOME
Depreciation, supplemental118.436.01
Cash interest paid, supplemental000
Cash taxes paid, supplemental0.060.050.04
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.